Viewing Study NCT00055302


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-05-21 @ 6:49 PM
Study NCT ID: NCT00055302
Status: COMPLETED
Last Update Posted: 2015-09-01
First Post: 2003-02-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Arimidex in McCune Albright Syndrome
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None McCune-Albright Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaginal bleeding View
None advanced bone age View
None fibrous dysplasia View
None MAS View
None McCune-Albright Syndrome View